Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 4.75 | -1.04% | -0.05 |
VRCA closed down 1.04 percent on Monday, March 18, 2024, on 66 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | -1.04% | |
Down 3 Days in a Row | Weakness | -1.04% | |
Down 4 Days in a Row | Weakness | -1.04% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 15 hours ago |
Down 3% | about 17 hours ago |
Fell Below Lower Bollinger Band | about 17 hours ago |
Fell Below Previous Day's Low | about 18 hours ago |
Down 2 % | about 18 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/29/2024
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.755 |
52 Week Low | 2.86 |
Average Volume | 137,011 |
200-Day Moving Average | 4.99 |
50-Day Moving Average | 5.49 |
20-Day Moving Average | 5.18 |
10-Day Moving Average | 5.00 |
Average True Range | 0.33 |
RSI (14) | 39.39 |
ADX | 16.24 |
+DI | 14.67 |
-DI | 26.71 |
Chandelier Exit (Long, 3 ATRs) | 5.01 |
Chandelier Exit (Short, 3 ATRs) | 5.60 |
Upper Bollinger Bands | 5.73 |
Lower Bollinger Band | 4.64 |
Percent B (%b) | 0.1 |
BandWidth | 21.07 |
MACD Line | -0.16 |
MACD Signal Line | -0.12 |
MACD Histogram | -0.0395 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.08 | ||||
Resistance 3 (R3) | 5.07 | 4.94 | 5.03 | ||
Resistance 2 (R2) | 4.94 | 4.86 | 4.95 | 5.01 | |
Resistance 1 (R1) | 4.85 | 4.81 | 4.79 | 4.86 | 4.99 |
Pivot Point | 4.72 | 4.72 | 4.69 | 4.73 | 4.72 |
Support 1 (S1) | 4.63 | 4.64 | 4.57 | 4.64 | 4.51 |
Support 2 (S2) | 4.50 | 4.59 | 4.51 | 4.49 | |
Support 3 (S3) | 4.41 | 4.50 | 4.48 | ||
Support 4 (S4) | 4.42 |